Stop Asking “Should I Patent This?” — Ask Which IP Bucket It Belongs In

Authored by Babak Akhlaghi on June 7, 2026.  Most founders treat IP protection as a single decision: should I patent this?

That’s the wrong question.

The right question is: which type of protection fits this idea, and what are the consequences if I get it wrong? That’s the foundation of a strategic patent approach that actually creates leverage.

The Elist v. Cornell case is a masterclass in what happens when you skip this question entirely. Dr. Elist shared his medical implant improvements under an NDA. The other side filed patents. A jury awarded him eighteen million dollars.

Then the Federal Circuit tore most of it apart.

Not because the NDA was missing. Not because the disclosure didn’t happen. But because Dr. Elist put his ideas in the wrong bucket from the start.

The Three Buckets You Need to Know

Before any disclosure, you need to understand where your idea actually belongs. Each bucket has different logic, different risk, different strategic consequences.

Patent: Public Disclosure for Time-Limited Monopoly

You give up secrecy in exchange for the right to exclude competitors for up to 20 years.

Best when you want to block competitors and your idea can survive a prior art search.

File a provisional first. It’s your timestamp at the USPTO and your insurance policy against NDA violations. If someone breaks the NDA and tries to file their own patent, you already have priority. You can sue them not just for breach of contract, but for willful patent infringement.

Trade Secret: Indefinite Protection with Real Conditions

Protection lasts as long as the information stays secret. No time limit.

But only if the information is genuinely not publicly known AND you treat it as confidential in practice AND your drive commercial value from the information.

Not just in your NDA. In every email. Every disclosure. Every room you let someone into.

The moment someone else publishes it in a patent application, your trade secret protection vanishes. Even if that patent never becomes a commercial product.

Defensive Publication: Blocking Others from Patenting

You intentionally publish the idea to prevent anyone else from claiming it as their own patent.

Useful when the idea isn’t patentable or worth the cost of patenting, but you want to block competitors from locking it up.

You give up exclusivity, but you keep the playing field open.

What the Penuma Case Proved

Dr. Elist tried to protect his implant improvements as trade secrets.

The Federal Circuit found those same improvements in prior art patents from 1980 and 1992.

The trade secret protection had already been extinguished by someone else’s patent filing before Dr. Elist ever shared the ideas with Dr. Cornell.

He didn’t know. The court didn’t care.

Dr. Elist argued that the improvements weren’t really “generally known” because they were never commercialized. The court rejected that argument completely. Once an idea is disclosed in a published patent application, it becomes generally known. Full stop.

Commercialization is irrelevant.

The NDA had a provision excluding information that was “generally known or becomes generally known.” Dr. Elist walked the defendant right through that escape hatch by claiming information that was already public.

There was also an instrument list shared by email. The email said the information “may” be confidential. It didn’t specifically label the attachment as confidential. And the list was shared with other people not under NDA.

Three fatal flaws: (1) wishy-washy language, (2) sloppy execution, and (3) sharing confidential information with a third party not under any obligation to keep the information confidential.

The same prior art that killed the trade secret claim also collapsed the inventorship argument. Dr. Elist claimed he should have been named as an inventor on the patents Dr. Cornell filed. But his contributions were limited to the trade secret information, which the court had already ruled was generally known. No significant contribution. No inventorship.

The Provisional as the Bridge

If patenting is the right bucket, file a strategic provisional before any disclosure.

Not a rushed, thin provisional. One that covers the core aspects of your invention, the aspects that competitors actually care about.

This stops the time bar. It establishes your priority date. And it converts any future NDA violation into a willful patent infringement claim.

You’re not chasing someone for breach of contract years later. You’re coming at them with a patent infringement claim. That’s a completely different conversation.

The provisional gives you time to turn your idea into a full non-provisional application. But it only works if it’s strategic from day one.

What This Case Cost Beyond Legal Fees

Dr. Elist lost more than the lawsuit.

He now has a competitor in the market. A competitor producing an improved product. That’s market share he can’t get back.

If he had filed a patent application on those improvements instead of treating them as trade secrets, the conversation with Dr. Cornell would have been entirely different. Assuming the patent sailed through the USPTO, he could have excluded the competitor or forced a licensing deal.

But the same prior art that killed his trade secret claim would have been the weapon used against a patent. He may have been caught either way.  However, the standard for patentability is a different standard than trade secrete, generally known, which is a broader standard.

That’s the brutal lesson here: you need to know what’s in the prior art before you decide which bucket your idea belongs in.

Be Strategic Before You Walk Into the Room

Don’t rush to file a patent application on everything. Assigning all ideas to a patenting bucket is wrong.

Some ideas fall in a patenting bucket. Some ideas fall in a trade secret bucket. Some ideas may fall into a completely different bucket, such as defensive publication.

Talk to an IP attorney. Do a patentability search. Understand what’s already public. Build a patent strategy that creates real leverage, not just paperwork.

If patenting is the right approach, file a strategic application, provisional or non-provisional. Make sure it covers the core aspects of your invention, the aspects that competitors care about.

If trade secret protection is the right approach, treat the information as confidential in practice. Not just in your NDA. Label confidential documents as confidential. Review your NDA provisions. Avoid boilerplate language that doesn’t actually protect you.

And if you’re about to disclose important technology to an investor, a partner, or a potential competitor, know which bucket your idea belongs in before you walk into that room.

The time bar starts ticking the moment you disclose. Once it expires, the idea is dedicated to the public. You’re left with no choice but to compete in an open market.

Be strategic about your IP. Know the buckets. Know the consequences. And protect yourself before the damage is done.